ImmunoForge (Co-CEOs Sung-Min Ahn and Ki-Ho Chang), a biotech venture specializing in the development of therapeutics for rare diseases, announced that it has been finally selected for the 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results